Mouse Camk1d (N-term), 39-67 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Mouse Camk1d (N-term), 39-67 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityMouse Camk1d (N-term), 39-67
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatpeptide affinity purified
Size0.08 mL, 0.4 mL
Concentrationvial concentration: 0.5
ApplicationsWestern Blot (WB), ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis Mouse Camk1d antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 39-67 amino acids from the N-terminal region of mouse Camk1d. Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium influx, activates CREB-dependent gene transcription, regulates calcium-mediated granulocyte function and respiratory burst and promotes basal dendritic growth of hippocampal neurons. In neutrophil cells, required for cytokine-induced proliferative responses and activation of the respiratory burst. Phosphorylates the transcription activator CREB1 on 'Ser-133' in hippocampal neuron nuclei. May play a role in apoptosis of erythroleukemia cells.
Immunogenn/a
Other Names[Calcium/calmodulin-dependent protein kinase type 1D; CaM kinase I delta; CaM-KI delta; CaMKI delta; CaM kinase ID; CaMKI-like protein kinase; CKLiK; mCKLiK; Camk1d]
Gene, Accession #[Camk1d], Gene ID: 227541, NCBI: NP_796317.2, UniProt: Q8BW96
Catalog #MBS9212742
Price$165, $370
Order / More InfoMouse Camk1d (N-term), 39-67 Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.